Keytruda 100mg Injections (Pembrolizumab)
US$ 5,397
Buy Pembrolizumab Injection Online, which is an Anti-Cancer medication, and contains Pembrolizumab. Keytruda 100 mg Injection are cancer medications, which lowers the growth of cancer cells in the body. Pembrolizumab Injection can only be prescribed by a licensed practitioner.
| Active Ingredient | |
|---|---|
| Strength | 100mg |
| Dosage Form | Injection |
| Manufacturer | Merck & Co |
| Packaging | 4 ml injection in a vial |
| Delivery Time | 12-18 Working Days |
Description
Buy Pembrolizumab Injection Online, which is a prescribed medication for the treatment of non-small cell lung cancer, head and neck cancer, and cervical, and melanoma cancer. Pembrolizumab is an active component present that works by blocking the activity of a molecule called PD-1, a protein that prevents T cells from recognizing and attacking inflamed tissues and cancer cells.
How to Use Keytruda 100mg Injections?
Keytruda 100 mg Injection is given under the skin or in the vein by a doctor or a nurse. Do not try to self-administer. Pembrolizumab Injection is given every three weeks until the disease recurrence or up to 12 months in patients without disease recurrence and 24 months in patients without disease progression.
Side Effects of Pembrolizumab 100 mg Injections:
The most common side effects of Keytruda 100 mg Injection are fatigue, rash, fever, stomach pain, bone, muscle, or joint pain, nausea, itching, indigestion, constipation, decreased appetite, diarrhea, and cough. It also causes certain serious side effects like shortness of breath, pale skin, bloody or cloudy urine, rapid heartbeats, and hair loss.
FAQS:
What types of cancer can Keytruda 100mg treat?
Keytruda 100mg is approved for the treatment of various types of cancers, including melanoma, non-small cell lung cancer (NSCLC), head and neck squamous cell carcinoma (HNSCC), classical Hodgkin lymphoma, urothelial carcinoma, microsatellite instability-high (MSI-H) or mismatch repair deficient (dMMR) solid tumors, and others. It is important to consult with a healthcare professional to determine if Keytruda is appropriate for a specific type and stage of cancer.
How long does Keytruda treatment last?
The duration of Keytruda treatment depends on the type and stage of the cancer being treated, as well as individual response and tolerability. Some patients may receive Keytruda for a few months, while others may require longer treatment courses. Treatment duration is typically determined by the healthcare provider based on ongoing evaluation and assessment of the patient’s condition.
Reference:
https://www.accessdata.fda.gov/drugsatfda_docs/label/2016/125514s012lbl.pdf
Spouse was determined to have arranged 4 on little cell lung malignant growth in April 2017 after heart medical procedure.
Was put on it in the first place, and I accept this is the main thing keeping him alive.
I have never been wipe out or frail, no issue except hard to breathe on occasion.